𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical image: Hidden costs of anti–tumor necrosis factor α therapy

✍ Scribed by D. Mulherin; T. P. Sheeran

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
71 KB
Volume
48
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infections and anti–tumor necrosis facto
Infections and anti–tumor necrosis factor α therapy
✍ Todd Ellerin; Robert H. Rubin; Michael E. Weinblatt 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

disease, 2 with pleural disease, and 1 each with paravertebral, meningeal, genital, bladder, enteric, and bone disease.

Antiangiogenic effects of anti–tumor nec
Antiangiogenic effects of anti–tumor necrosis factor α therapy with infliximab in psoriatic arthritis
✍ Juan D. Cañete; José L. Pablos; Raimon Sanmartí; Carmen Mallofré; Sara Marsal; J 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 1 views

## Abstract ## Objective Neovascularization, with an increased number of synovial vessels with a characteristic morphology, seems to contribute to the progression of psoriatic arthritis (PsA). Accordingly, angiogenesis may be an important therapeutic target in PsA. The aim of this study was to ana

Physician preference motivates the use o
Physician preference motivates the use of anti–tumor necrosis factor therapy independent of clinical disease activity
✍ Jeffrey R. Curtis; Lang Chen; Leslie R. Harrold; Pongthorn Narongroeknawin; Geor 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 82 KB

## Abstract ## Objective Physician preference has previously been shown to be an important determinant of prescription patterns, independent of patient‐specific factors. We evaluated whether physician preference was important in the decision to select anti–tumor necrosis factor (anti‐TNF) therapy